Takara Bio Inc. (OTCMKTS:TKBIF) Short Interest Down 40.7% in October

Takara Bio Inc. (OTCMKTS:TKBIF) saw a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 14,400 shares, a decline of 40.7% from the October 15th total of 24,300 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Takara Bio Stock Performance

Shares of Takara Bio stock remained flat at $23.20 during trading on Thursday. The stock has a 50-day moving average price of $23.20 and a two-hundred day moving average price of $23.20. Takara Bio has a twelve month low of $23.20 and a twelve month high of $23.20.

Takara Bio Company Profile

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.